Salla disease is a dubious disease in the field of genetic metabolism, clinical performance is complex and often involves multiple systems. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of Salla disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
Platforms can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of Salla disease requires the development of multiple treatment regimens, usually including drug therapy, rehabilitation interventions, and regular follow-up management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult-to-treat genetic metabolic disorders.
Treatment requires close monitoring of therapeutic effects and adverse reactions, with timely adjustment to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Salla disease. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.